Christopher R Sudfeld1, Sylvia Kaaya, Nilupa S Gunaratna, Fedinand Mugusi, Wafaie W Fawzi, Said Aboud, Mary C Smith Fawzi. 1. aDepartment of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA bDepartment of Psychiatry and Mental Health cDepartment of Internal Medicine, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania dDepartment of Epidemiology eDepartment of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA fDepartment of Microbiology and Immunology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania gDepartment of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, USA.
Abstract
OBJECTIVE: The objective of the study was to assess the relationship of depression at antiretroviral therapy (ART) initiation with mortality and clinical outcomes among Tanzanian women living with HIV. DESIGN: We conducted a prospective cohort study of 1487 women who initiated ART in Dar es Salaam, Tanzania. METHODS: Symptoms of depression and anxiety were assessed using a Tanzanian-adapted and validated version of the Hopkins Symptom Checklist. Participants attended monthly clinic visits during the first 2 years of ART and CD4 T-cell counts were assessed every 4 months. Proportional hazard models were used to assess the relationship of depression with mortality and clinical outcomes. RESULTS: Symptoms consistent with depression were prevalent among 57.8% of women at ART initiation. After multivariate adjustment, including social support and stigma, depression at ART initiation was associated with increased risk of mortality [hazard ratio (HR): 1.92; 95% confidence interval (CI): 1.15-3.20; P = 0.01] and incidence of severe anemia (hemoglobin <8.5 g/dl; HR: 1.59; 95% CI: 1.07-2.37; P = 0.02). Under the assumption of causality, we estimate 36.1% (95% CI: 13.6-55.1%) of deaths among the study cohort were attributable to depression and its consequences. Depression was not significantly associated with trajectory of CD4 T-cell reconstitution or the risk of immunologic failure (P values >0.05). CONCLUSION: Elimination of depression may reduce mortality during the first 2 years of ART by one-third in our study cohort. Randomized trials and rigorous implementation studies are needed to evaluate the individual and population-level effects of integrated mental health interventions and HIV treatment approaches in resource-limited settings.
OBJECTIVE: The objective of the study was to assess the relationship of depression at antiretroviral therapy (ART) initiation with mortality and clinical outcomes among Tanzanian women living with HIV. DESIGN: We conducted a prospective cohort study of 1487 women who initiated ART in Dar es Salaam, Tanzania. METHODS:Symptoms of depression and anxiety were assessed using a Tanzanian-adapted and validated version of the Hopkins Symptom Checklist. Participants attended monthly clinic visits during the first 2 years of ART and CD4 T-cell counts were assessed every 4 months. Proportional hazard models were used to assess the relationship of depression with mortality and clinical outcomes. RESULTS: Symptoms consistent with depression were prevalent among 57.8% of women at ART initiation. After multivariate adjustment, including social support and stigma, depression at ART initiation was associated with increased risk of mortality [hazard ratio (HR): 1.92; 95% confidence interval (CI): 1.15-3.20; P = 0.01] and incidence of severe anemia (hemoglobin <8.5 g/dl; HR: 1.59; 95% CI: 1.07-2.37; P = 0.02). Under the assumption of causality, we estimate 36.1% (95% CI: 13.6-55.1%) of deaths among the study cohort were attributable to depression and its consequences. Depression was not significantly associated with trajectory of CD4 T-cell reconstitution or the risk of immunologic failure (P values >0.05). CONCLUSION: Elimination of depression may reduce mortality during the first 2 years of ART by one-third in our study cohort. Randomized trials and rigorous implementation studies are needed to evaluate the individual and population-level effects of integrated mental health interventions and HIV treatment approaches in resource-limited settings.
Authors: Usha S Govindarajulu; Donna Spiegelman; Sally W Thurston; Bhaswati Ganguli; Ellen A Eisen Journal: Stat Med Date: 2007-09-10 Impact factor: 2.373
Authors: Sheila Isanaka; Ferdinand Mugusi; Claudia Hawkins; Donna Spiegelman; James Okuma; Said Aboud; Chalamilla Guerino; Wafaie W Fawzi Journal: JAMA Date: 2012-10-17 Impact factor: 56.272
Authors: Judith A Cook; Dennis Grey; Jane Burke; Mardge H Cohen; Alejandra C Gurtman; Jean L Richardson; Tracey E Wilson; Mary A Young; Nancy A Hessol Journal: Am J Public Health Date: 2004-07 Impact factor: 9.308
Authors: Viviane D Lima; Josie Geller; David R Bangsberg; Thomas L Patterson; Mark Daniel; Thomas Kerr; Julio S G Montaner; Robert S Hogg Journal: AIDS Date: 2007-05-31 Impact factor: 4.177
Authors: Jennifer Velloza; Connie Celum; Jessica E Haberer; Kenneth Ngure; Elizabeth Irungu; Nelly Mugo; Jared M Baeten; Renee Heffron Journal: AIDS Behav Date: 2017-08
Authors: Pragna Patel; Charles E Rose; Pamela Y Collins; Bernardo Nuche-Berenguer; Vikrant V Sahasrabuddhe; Emmanuel Peprah; Susan Vorkoper; Sonak D Pastakia; Dianne Rausch; Naomi S Levitt Journal: AIDS Date: 2018-07-01 Impact factor: 4.177
Authors: Angela M Parcesepe; Evette Cordoba; John A Gallis; Jennifer Headley; Berenger Tchatchou; John Hembling; Claudian Soffo; Joy Noel Baumgartner Journal: BMC Pregnancy Childbirth Date: 2021-03-04 Impact factor: 3.007
Authors: Mathilda Regan; Alfa Muhihi; Tumaini Nagu; Said Aboud; Nzovu Ulenga; Sylvia Kaaya; Mary C Smith Fawzi; Aisha K Yousafzai; Ferdinand Mugusi; Wafaie W Fawzi; Shekhar Saxena; Karestan Koenen; Christopher R Sudfeld Journal: AIDS Behav Date: 2021-02-17
Authors: Noeline Nakasujja; Alyssa C Vecchio; Deanna Saylor; Sarah Lofgren; Gertrude Nakigozi; David R Boulware; Alice Kisakye; James Batte; Richard Mayanja; Aggrey Anok; Steven J Reynolds; Thomas C Quinn; Carlos A Pardo; Anupama Kumar; Ronald H Gray; Maria J Wawer; Ned Sacktor; Leah H Rubin Journal: J Neurovirol Date: 2021-07-31 Impact factor: 3.739
Authors: Angela M Parcesepe; Catrina Mugglin; Fred Nalugoda; Charlotte Bernard; Evy Yunihastuti; Keri Althoff; Antoine Jaquet; Andreas D Haas; Stephany N Duda; C William Wester; Denis Nash Journal: J Int AIDS Soc Date: 2018-03 Impact factor: 5.396
Authors: Catherine E Oldenburg; Katrina F Ortblad; Michael M Chanda; Magdalene Mwale; Steven Chongo; Catherine Kanchele; Nyambe Kamungoma; Andrew Fullem; Till Bärnighausen Journal: J Acquir Immune Defic Syndr Date: 2018-12-01 Impact factor: 3.731